Bechara Carlos, Chai Hong, Lin Peter H, Yao Qizhi, Chen Changyi
Molecular Surgeon Research Center, Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
Med Sci Monit. 2007 Jun;13(6):RA87-90.
Growth related oncogene-alpha (GRO-alpha) is a member of the CXC chemokine family with an internal glutamate-leucine-arginine (ELR) motif. It was initially isolated and characterized by its growth stimulatory activity on malignant melanoma cells. Recently, many new functions and properties of GRO-alpha have been discovered and associated with atherosclerosis, angiogenesis and many inflammatory conditions. Purpose of this review is to overview current advances of multiple functions of GRO-alpha and its associated molecular mechanisms and clinical implications. We hope to further evaluate this molecule in the pathogenesis of atherosclerosis as well as angiogenesis to promote a background for therapeutic interventions.
生长相关癌基因α(GRO-α)是CXC趋化因子家族的成员,具有内部谷氨酸-亮氨酸-精氨酸(ELR)基序。它最初是通过其对恶性黑色素瘤细胞的生长刺激活性而被分离和鉴定的。最近,人们发现了GRO-α的许多新功能和特性,并将其与动脉粥样硬化、血管生成和许多炎症性疾病联系起来。本综述的目的是概述GRO-α多种功能的当前进展及其相关的分子机制和临床意义。我们希望进一步评估该分子在动脉粥样硬化发病机制以及血管生成中的作用,为治疗干预提供背景依据。